Skip to Main Content

Paper Details

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
Nat Commun
32
2022
COVID-19, Children, MIS-C, Omicron, Omicron variant, SARS, SARS-CoV, SARS-CoV-2, children, patients, pediatric
Author NameAffiliation
Natasha B HalasaVanderbilt University Medical Center
Tracie C WalkerUniversity of North Carolina at Chapel Hill Children's Hospital
Shira J GertzCooperman Barnabas Medical Center
Natalie Z CvijanovichUCSF Benioff Children's Hospital Oakland
Laura L LoftisBaylor College of Medicine
Julie C FitzgeraldThe University of Pennsylvania Perelman School of Medicine
Courtney M RowanIndiana University School of Medicine, Riley Hospital for Children
Aline B MadduxUniversity of Colorado School of Medicine and Children's Hospital Colorado
Adriana H TremouletKawasaki Disease Research Center, Rady Children's Hospital and Department of Pediatrics, university of california san diego School of Medicine
Chisato ShimizuKawasaki Disease Research Center, Rady Children's Hospital and Department of Pediatrics, university of california san diego School of Medicine
Jane C BurnsKawasaki Disease Research Center, Rady Children's Hospital and Department of Pediatrics, university of california san diego School of Medicine
Christoph LangeHarvard T.H. Chan School of Public Health
Adrienne G RandolphBoston Children's Hospital
Adrienne G RandolphHarvard Medical School
Adrienne G RandolphBoston Children's Hospital and Harvard Medical School
  • 1 - 15

Datasets